Medical Disclaimer: This information is educational only and does not constitute medical advice. Cannabis affects everyone differently. Always consult a qualified healthcare provider before using cannabis, especially if you take other medications. Never discontinue prescribed medications without medical supervision.

Overview: Understanding Chronic Pain

Chronic pain — defined as pain lasting three months or longer — affects an estimated 50 million American adults, with approximately 20 million experiencing pain severe enough to limit daily activities. It is the leading cause of disability worldwide and one of the most common reasons people seek medical care.

Chronic pain is not simply acute pain that lasts longer. Over time, persistent pain can reshape the nervous system itself, with pain pathways becoming sensitized and amplified. This is why chronic pain can persist even after an initial injury has healed, and why it often requires different treatment approaches than acute pain.

Types of Chronic Pain

Chronic pain is not a single condition. Understanding the type of pain you experience matters because different mechanisms may respond differently to cannabis:

Neuropathic pain — caused by damage or dysfunction in the nervous system itself. Includes conditions like diabetic neuropathy, sciatica, post-surgical nerve damage, and fibromyalgia. Often described as burning, shooting, tingling, or electric-shock sensations.
Inflammatory pain — caused by the body's immune response. Includes arthritis, inflammatory bowel disease, and autoimmune conditions. Typically presents as aching, swelling, stiffness, and warmth.
Cancer-related pain — may involve both neuropathic and inflammatory components, plus pain from tumors pressing on nerves or organs. Often managed with opioids, which carry their own significant burden.
Centralized pain — involves changes in how the central nervous system processes pain signals. Includes conditions like fibromyalgia and chronic widespread pain, where pain signals are amplified by the brain and spinal cord.

Conventional Treatment

Standard pain management typically follows a stepped approach:

Over-the-counter medications — NSAIDs (ibuprofen, naproxen) and acetaminophen for mild to moderate pain. Effective for many, but long-term NSAID use carries risks of gastrointestinal bleeding, kidney damage, and cardiovascular events.
Physical therapy and exercise — a cornerstone of pain management with strong evidence, often underutilized.
Prescription medications — including gabapentinoids (gabapentin, pregabalin), SNRIs (duloxetine), muscle relaxants, and topical treatments. Each has its own efficacy and side effect profile.
Opioid medications — hydrocodone, oxycodone, morphine, and others. Highly effective for acute and cancer-related pain, but carry significant risks for chronic non-cancer pain: physical dependence, tolerance (requiring increasing doses), constipation, sedation, hormonal disruption, and the risk of opioid use disorder. The opioid crisis has made both patients and providers acutely aware of these risks.
Interventional procedures — nerve blocks, spinal cord stimulators, joint injections, and other procedures targeting specific pain generators.

Many chronic pain patients cycle through multiple treatments, often settling on regimens that provide partial relief with tolerable side effects. It is in this context — where existing treatments are imperfect — that cannabis has attracted the most attention.

What the Research Says

The evidence on cannabis for chronic pain is mixed but increasingly detailed — and some of the most compelling data centers on opioid reduction rather than direct pain relief alone.

Evidence Suggesting Benefit

Cannabis and Opioid Reduction

The most striking research on cannabis and chronic pain relates to its potential to reduce opioid dependence. Multiple studies from different countries and healthcare systems point in the same direction:

A landmark 2025 study published in JAMA Internal Medicine tracked 204 chronic pain patients in New York’s Medical Cannabis Program over 18 months. Participants reduced their average daily opioid dose from 73.3 mg morphine equivalent to 57 mg — a 22% reduction. Those receiving a 30-day supply of cannabis used 3.5 fewer mg of morphine equivalent per day than those receiving no cannabis in the same month.
Slawek et al., JAMA Internal Medicine, 2025

A University of Georgia study found that medical cannabis legalization led to a 16% reduction in opioid prescription rates across all demographics.
Lozano-Rojas et al., University of Georgia / JAMA Health Forum, 2025

An Australian study found that pain patients receiving cannabis extracts reduced their average opioid intake to 2.7 mg/day after one year, compared to 42.3 mg/day in the control group. These patients also experienced decreases in depression, anxiety, insomnia, and disability.
NORML, 2025

A large Canadian prospective study tracking 1,145 patients found that baseline opioid use dropped from 28% of participants to 11% at 6 months, with a 78% reduction in mean opioid dosage.
Lucas et al., Pain Medicine, 2021

Why opioid reduction matters: Even if cannabis provided only modest direct pain relief, any treatment that helps patients safely reduce opioid use represents a significant clinical and public health benefit. Opioid side effects, dependence, and overdose risk are among the most serious challenges in modern pain management.

Patient-Reported Quality of Life

A UK survey of 1,669 medical cannabis users found that nearly 89% of those with chronic pain reported improved quality of life.
UK Medical Cannabis Registry, 2025

While patient-reported outcomes are not the same as clinical trial data, the consistency and scale of these reports — across different countries, healthcare systems, and study designs — adds weight to the evidence. Quality of life improvements include not just pain reduction but better sleep, improved mood, and greater ability to participate in daily activities.

FDA-Approved Cannabinoid Medications

Two synthetic cannabinoid medications have received FDA approval for conditions involving pain and discomfort:

Dronabinol (Marinol, Syndros) — synthetic THC, approved for chemotherapy-related nausea and HIV/AIDS-related appetite loss. Has shown modest pain reduction in some studies.
Nabilone (Cesamet) — a synthetic cannabinoid approved for chemotherapy-related nausea. Some research suggests analgesic properties, particularly for neuropathic pain.

Evidence Raising Concern

The 2025 JAMA review, which examined more than 2,500 studies, noted that current clinical guidelines do not recommend cannabis as a first-line treatment for chronic pain.
Hsu et al., JAMA / UCLA Health, 2025

The 2025 OHSU living review found that while oral THC-containing products slightly reduced pain severity, products mainly containing CBD showed almost no pain benefit — contrary to widespread marketing claims for CBD pain products.
OHSU, Annals of Internal Medicine, 2025

Additional concerns from the literature:

Approximately 29% of medical cannabis users in the JAMA review met criteria for cannabis use disorder — a higher rate than in the general cannabis-using population.
The pain-relieving effects of cannabis appear to be modest in magnitude. Cannabis is not a powerful analgesic in the way that opioids are. Its value may lie more in improving overall function and reducing the need for more harmful medications.
Tolerance can develop with regular use, potentially requiring dose increases over time.
Inhaled cannabis carries lung health risks when smoked.

Cannabis for Neuropathic Pain

Neuropathic pain is the pain type with the strongest evidence base for cannabis treatment. This makes sense biologically: CB1 receptors are concentrated in the nervous system, and cannabinoids appear to modulate pain signaling at multiple points along nerve pathways.

Several randomized controlled trials have shown that inhaled cannabis reduces neuropathic pain compared to placebo, with number needed to treat (NNT) values comparable to established neuropathic pain medications.
Nabiximols (Sativex), a pharmaceutical-grade THC:CBD spray available in some countries (not FDA-approved in the U.S.), has shown efficacy in multiple sclerosis-related neuropathic pain.
Low-dose vaporized THC (1 to 4 puffs of low-potency flower) has shown meaningful pain reduction in HIV-associated neuropathy studies.

If you have neuropathic pain, the evidence for cannabis is stronger than for other pain types, though it still does not rise to first-line recommendation status in current clinical guidelines.

Cannabis for Inflammatory Pain

Both THC and CBD have demonstrated anti-inflammatory properties in preclinical research, though the clinical evidence in humans is less developed than for neuropathic pain.

THC and CBD both interact with immune system pathways that regulate inflammation.
CB2 receptors are concentrated in immune system tissues and play a role in modulating inflammatory responses.
The terpene beta-caryophyllene is of particular interest for inflammatory pain because it directly activates CB2 receptors without producing psychoactive effects. Found in black pepper, cloves, and many cannabis varieties, it may contribute to anti-inflammatory effects. Some researchers consider it a "dietary cannabinoid."
Topical cannabis products (creams, balms, patches) may provide localized anti-inflammatory and pain-relieving effects for joint and muscle pain without systemic psychoactive effects.

Patient reports frequently describe improvement in arthritis symptoms, but large-scale clinical trials specifically examining cannabis for inflammatory arthritis are limited.

Cannabis for Cancer-Related Pain

Cancer pain management is one of the areas where cannabis has the longest history of medical use, and where the therapeutic rationale is clearest:

FDA-approved synthetic cannabinoids (dronabinol, nabilone) are already part of the cancer care toolkit, primarily for chemotherapy-induced nausea but with secondary analgesic benefits.
Cannabis may address multiple symptoms simultaneously — pain, nausea, appetite loss, insomnia, and anxiety — which is particularly valuable for cancer patients dealing with symptom clusters.
The potential to reduce opioid doses is especially relevant in cancer care, where opioid side effects (constipation, sedation, nausea) can compound an already difficult symptom burden.
Some oncology centers now incorporate cannabis consultations into their supportive care programs.

If you are a cancer patient, discuss cannabis with your oncology team. Drug interactions with chemotherapy agents are a real concern and require medical oversight. See our Drug Interactions page.

How People Use Cannabis for Chronic Pain

The following section describes patterns reported by patients and in surveys. This is anecdotal and observational evidence, not clinical guidance. Individual responses to cannabis vary widely.

Full-spectrum products — Many pain patients report that whole-plant or full-spectrum products (containing multiple cannabinoids and terpenes) are more effective than single-compound products. This aligns with the "entourage effect" theory, though controlled research on this is still limited.
Combination with existing treatments — Rather than replacing their pain medications entirely, many patients report using cannabis as an adjunct that allows them to reduce doses of other medications under medical supervision.
Daytime vs. nighttime regimens — Some patients use lower-THC products during the day (to manage pain without significant impairment) and higher-THC products at night (when sedation is acceptable and sleep is a secondary goal).
Topicals for localized pain — Patients with arthritis, muscle pain, or localized nerve pain frequently report using topical cannabis products directly on affected areas, sometimes in combination with oral or inhaled products for systemic relief.
Edibles for long-duration relief — Many chronic pain patients prefer edibles or tinctures for their longer duration of action (4 to 8 hours), which reduces the need for frequent redosing throughout the day.
Tracking and titration — Pain patients who report the most success often describe a deliberate, journal-based process of experimenting with different products, doses, and timing over weeks to months before finding their optimal regimen.

Recommended Starting Points

These are general guidelines based on research patterns and patient reports, not prescriptions. Always consult your healthcare provider, especially if you currently take opioids or other pain medications.

Cannabinoid Profiles

Start with 2.5 to 5 mg THC. Unlike anxiety (where lower is almost always better), pain management may require slightly higher THC doses, but the "start low, go slow" principle still applies.
Consider full-spectrum products. Products containing multiple cannabinoids (THC, CBD, CBG, CBN) and terpenes may provide broader pain relief than isolated compounds, based on the entourage effect theory.
CBD alone is likely insufficient for significant pain. The 2025 OHSU review found that CBD-only products showed almost no pain benefit. If you are using CBD for pain, it may be more effective in combination with THC.
THC:CBD ratios of 1:1 or 2:1 are commonly reported as effective for pain while moderating psychoactive intensity.

The Beta-Caryophyllene Connection

Among terpenes, beta-caryophyllene deserves special attention for pain patients. Unlike most terpenes, beta-caryophyllene directly binds to CB2 receptors in the immune system and has demonstrated anti-inflammatory and analgesic properties in research. It does not produce psychoactive effects.

Found in high concentrations in black pepper, cloves, cinnamon, hops, and many cannabis varieties
Some researchers have classified it as a "dietary cannabinoid" due to its direct CB2 receptor activity
May be particularly relevant for inflammatory pain conditions
Look for it on product lab results — cannabis products with high beta-caryophyllene content may offer additional pain-relief benefits

Other terpenes of interest for pain include myrcene (muscle relaxant, sedative), linalool (analgesic, anti-inflammatory), and alpha-pinene (anti-inflammatory). Learn more on our Cannabinoids & Terpenes page.

Consumption Methods for Pain

Method	Onset	Duration	Best For	Considerations
Edibles / capsules	30–90 min	4–8 hours	Sustained, around-the-clock pain; nighttime use	Slower onset; stronger effect due to first-pass metabolism; harder to titrate
Tinctures (sublingual)	15–30 min	4–6 hours	Flexible dosing; moderate duration; good for titration	Good balance of precision and duration
Vaporization	1–5 min	1–3 hours	Breakthrough pain; rapid relief when needed	Shorter duration requires more frequent dosing; lung health considerations
Topicals	15–45 min	2–4 hours	Localized joint/muscle pain; arthritis; no psychoactive effects	Only works at the application site; does not enter bloodstream significantly
Transdermal patches	30–60 min	8–12 hours	Sustained systemic relief; consistent dosing	Less widely available; limited product variety; does enter bloodstream

For chronic pain management: Many patients find a combination approach most effective — for example, a tincture or edible for baseline daily pain management, combined with vaporization for breakthrough pain episodes, and a topical for localized flare-ups. Your optimal approach will depend on your pain type, schedule, and tolerance for psychoactive effects. Learn more on our Methods of Consumption page.

Dosing Protocol for Pain

Day 1–3: Start with 2.5 to 5 mg THC (or an equivalent 1:1 THC:CBD dose). Use in the evening first to gauge your response without daytime obligations.
Days 4–7: If well tolerated but insufficient, increase by 2.5 mg. If side effects occur, reduce the dose or add more CBD.
Weeks 2–4: Continue gradual titration. Many pain patients find their effective dose in the 5 to 15 mg THC range, though this varies widely.
Ongoing: Track your pain levels, function, mood, and sleep in a journal. Share this data with your healthcare provider. The goal is the minimum effective dose that improves your quality of life.
If you take opioids: Do NOT reduce your opioid dose on your own. Share your cannabis experience with your prescriber and let them guide any medication adjustments.

For more on dosing principles, see our Dosing Fundamentals page.

Risks & Considerations

Cannabis is not a first-line treatment. Current clinical guidelines do not recommend cannabis as a first-line pain medication. It is more appropriately considered when standard treatments have been insufficient, produce intolerable side effects, or when opioid reduction is a goal.
CBD alone may not help. Despite widespread marketing, the 2025 OHSU review found that CBD-only products showed almost no benefit for pain. If you have been using CBD products without improvement, this may be why.
Cannabis use disorder risk. Chronic pain patients using cannabis daily are at elevated risk for dependence. The 29% CUD rate in the JAMA review is a real concern. Be honest with yourself and your provider about your use patterns.
Tolerance development. With regular use, you may need increasing doses to achieve the same pain relief. Periodic tolerance breaks (with medical guidance if you take other medications) may help manage this.
Never stop opioids on your own. Even if cannabis is helping your pain, abruptly discontinuing opioids can cause severe, potentially dangerous withdrawal. Any opioid reduction must be supervised by your prescriber.
Drug interactions. Cannabis interacts with the CYP450 liver enzyme system and may affect how your body processes other pain medications, blood thinners, sedatives, and many other drugs. See our Drug Interactions page.
Cardiovascular considerations. Daily cannabis use, particularly inhaled or high-potency products, has been associated with elevated cardiovascular risks. If you have heart disease or risk factors, discuss this with your cardiologist.
Impairment and driving. THC impairs driving ability. Chronic pain patients who use cannabis during the day must account for impairment windows. See our Driving & Impairment page.
Smoking is the least recommended method. If you choose inhaled cannabis, vaporization is preferred over smoking. Combustion produces tar and carcinogens similar to tobacco smoke.

Critical Warning: Never stop taking prescribed medications without medical supervision. Abruptly discontinuing certain medications (especially opioids, benzodiazepines, SSRIs, and blood pressure medications) can cause serious, potentially life-threatening complications. Any changes to your medication regimen must be made under the guidance of your healthcare provider.

Talk to Your Doctor

Cannabis for chronic pain should always be discussed with your healthcare provider, and this conversation is especially important if you currently take opioids or other prescription pain medications.

How to Bring It Up

"I have been reading about research showing cannabis may help chronic pain patients reduce their opioid use. Can we discuss whether this might be appropriate for my situation?" Leading with the opioid-reduction angle frames the conversation around a goal most providers share.
"My current pain management is not giving me the quality of life I want. I would like to discuss whether cannabis could be part of a broader approach."
"I want to be transparent about something — I am considering cannabis for my pain, and I want to make sure it is safe with everything else I take."

What to Ask Your Doctor

Are there interactions between cannabis and my current pain medications?
Given my specific type of pain, what does the evidence suggest?
If cannabis helps, could we discuss a plan to gradually reduce my opioid dose under your supervision?
Would you be willing to monitor my progress and help me optimize this approach?
Are there cannabis-specialized clinics or providers you would recommend?

If Your Doctor Is Dismissive

Some providers remain skeptical, and some may have policies against recommending cannabis. If your doctor is unwilling to engage:

Ask specifically what concerns them — their hesitation may be valid and worth understanding
Contact the Society of Cannabis Clinicians for a provider trained in cannabis medicine
Consult Leaf411 for guidance from cannabis-trained registered nurses
Consider a pain management specialist or integrative medicine provider who may have more experience with cannabis as a complementary treatment

For a more detailed guide, visit our Talking to Your Doctor page.

Are You 21 or Older?

Cannabis for Chronic Pain